New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S1037

Introduced
1/31/22  

Caption

Requires pharmacy practice sites to document reasons for not filling certain prescriptions.

Impact

The enactment of S1037 would have several implications for pharmacy operations. Firstly, it would impose a duty on pharmacies to clarify and document cases where prescriptions are deemed unlawful or not filled due to stock issues. This could lead to improved accountability among pharmacies and provide patients with better knowledge about their options when a prescription cannot be fulfilled. Furthermore, the bill aims to address potential stigma surrounding the use of medications for mental health issues, seeking to dispel misconceptions associated with prescribed drugs.

Summary

Senate Bill S1037, introduced in the New Jersey Legislature, seeks to amend current pharmacy practices regarding the documentation required when a prescription is not filled. Specifically, the bill mandates that pharmacy practice sites must document the reasons for not filling certain prescriptions and provide an explanation to the patient and their prescribing physician within 48 hours of their decision. This requirement is aimed at enhancing transparency in prescription management and ensuring that patients receive timely communication about their medications.

Contention

While the bill has the potential to improve patient care and communication, it could also introduce challenges for pharmacy practice sites. Some may argue that this additional documentation requirement could lead to increased administrative burdens for pharmacists. Additionally, concerns may arise regarding the balance between a pharmacist's moral convictions and their professional responsibilities, especially for those who object to dispensing certain medications on ethical grounds. The broader impact of the bill will largely depend on how pharmacies implement these documentation processes and measure compliance.

Companion Bills

NJ A2022

Same As Requires pharmacy practice sites to document reasons for not filling certain prescriptions.

Previously Filed As

NJ S2298

Regulates Internet pharmacies and electronic prescriptions.

NJ S3381

Prohibits pharmacy benefits managers from operating pharmacy practice sites directly or indirectly.

NJ A4948

Prohibits pharmacy benefits managers from operating pharmacy practice sites directly or indirectly.

NJ HB1673

Mississippi Pharmacy Practice Act; bring forward provision relating to nonresident pharmacies.

NJ SB1309

pharmacists; care standard; prescriptions

NJ SB252

Pharmacy Benefits Managers; providing a prescription reimbursement rate for independent pharmacies and regulating other practices

NJ SB3223

PRACTICE OF PHARMACY

NJ S2891

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

NJ SB741

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

NJ SB741

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

Similar Bills

HI HB2225

Relating To Health.

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.

IA HSB99

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See HF 852.)

IA SSB1074

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See SF 383.)

IA HF852

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(Formerly HSB 99.)

CA AB577

Health care coverage: antisteering.

AZ SB1102

Pharmacy benefits; prescribing; exemption

TX SB493

Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.